Bloom Energy Corporation (NYSE: BE) — Right Horse, Ruinous Odds in the AI Power Crunch
An independent fundamental analysis Report date: 2026-06-10 Price (2026-06-09): $259.61 · Market cap: ~$82.5B · Enterprise value: ~$84.0B · 52-wk range: $18.12–$322.83 · Beta: 3.83 Sector: Industrials — Heavy Electrical Equipment (distributed power / solid-oxide fuel cells) · CIK: 0001664703
⚡ Claude’s Take
This block is the author’s own independent, subjective opinion. It is general information and not investment advice. The body of this report below deliberately carries no recommendation and no price target — valuation there is discussed only as embedded expectations and scenarios.
Verdict: HOLD / AVOID-at-this-price — a genuinely good business wearing a bubble’s price tag. Not a short (the squeeze and the real inflection make that reckless), but not a buy here. Accumulate only on a deep pullback into the ~$90–$140 zone. Tag: “Right horse, ruinous odds.”
The operational story is real and I want to be unambiguous about that: Bloom has crossed from cash-incinerating science project to a scaling, free-cash-flow-positive manufacturer with GAAP operating profit (+$73M FY25), gross margin that doubled to ~29%, a Service segment that finally turned profitable, and a Q1’26 revenue print of +130% YoY driven by a demand pool — on-site power for AI data centers — whose binding constraint (speed-to-power) is precisely Bloom’s core differentiator. Oracle’s 2.45 GW “Project Jupiter,” AEP’s $2.65B definitive order, and Brookfield’s up-to-$5B financing vehicle are not vapor; they are Tier-1 validation. If you only read the income statement’s trajectory, you would be excited.
But price is what you pay. At ~$84B EV the market is underwriting roughly 55–85% revenue CAGR through 2030 and a doubling of operating margin to ~20% and a retained premium multiple — simultaneously. My base case (a strong-but-decelerating ~48% CAGR to ~$14B revenue at mid-teens margins, 18x EBIT) pencils to roughly $135/share — about half the current price. The stock is priced for the bull case to be the base case, with zero margin of safety, at the 95th percentile of its own ten-year valuation history, into a single hyper-cyclical end-market, with ~43% of revenue from one (formerly related-party) counterparty, and a beta of 3.83 that guarantees it falls multiples of any AI-capex air-pocket. This is the Marathon capital-cycle setup in textbook form: stellar returns and a hot narrative pulling in capital (Bloom’s own 5 GW expansion, turbine OEMs, Doosan/Ceres in SOFC) that mean-reverts the scarcity premium around 2028–30. Framing: this is a quality-compounder-at-the-wrong-price / late-capital-cycle situation, not a value or contrarian entry.
Conviction: medium. The single piece of evidence that would flip me bullish: durable, diversified (multiple named hyperscalers each <15% of revenue) booking growth holding >60% with expanding GAAP margins through 2027, proving the moat outlasts the scarcity window — at a price that hasn’t already capitalized it. The single piece that would flip me outright bearish (toward “press the short”): a guided revenue deceleration below ~40% or a product-gross-margin roll-over below ~32%, either of which collapses the embedded math. Until the price comes to the business, I sit on my hands.
1. Executive Summary
Bloom Energy designs, manufactures, installs and services on-site (“behind-the-meter”) electric power systems built on a proprietary high-temperature solid-oxide fuel cell (SOFC) platform — the Bloom Energy Server — that converts natural gas, biogas, or hydrogen into electricity through a non-combustion electrochemical process. The same platform underpins a solid-oxide electrolyzer. After 25 years and ~1,100 sites, the business reached an unmistakable inflection in 2024–2025, and the stock has responded with a ~14x move off its 52-week low.
The operational facts are strong and corroborated. Revenue grew $1,135M (FY22) → $1,269M (FY23) → $1,441M (FY24) → $2,002M (FY25, +37%), and accelerated to +130% YoY in Q1’26 ($751M). GAAP gross margin doubled from 13% (FY22) to 29% (FY25); GAAP operating income inflected from -$261M (FY22) to +$73M (FY25); operating cash flow turned from -$372M (FY23) to +$114M (FY25) on strikingly low capex (~$57M, ~3% of revenue). The chronically loss-making Service segment turned profitable. Management raised FY26 guidance twice, most recently to $3.4–3.8B revenue (~80% growth) at ~34% non-GAAP gross margin. Cash stands at ~$2.45B against ~$2.6B of cheap (0%/3%-coupon) convertible debt.
The driver is the AI data-center power crunch, and it is well-evidenced rather than narrative: a ~2,300 GW U.S. interconnection queue, GE Vernova’s ~80 GW gas-turbine backlog sold out toward 2030, and ~160% projected growth in data-center electricity demand by 2030. Bloom’s pitch — energize a site in ~12 months versus 2029+ for turbines, with no combustion, less water, and faster permitting — won Oracle’s 2.45 GW “Project Jupiter” (turbines and diesel designed out), AEP’s up-to-1 GW agreement ($2.65B definitive in Jan 2026), and a Brookfield up-to-$5B financing framework.
But three things keep this short of an unqualified quality verdict, and one thing dominates the investment case. The qualifiers: (1) revenue is ~77% non-recurring product hardware — a lumpy, project-timed capital-equipment business, not a recurring-revenue compounder; (2) customer concentration is severe — the top customer was ~43% of FY25 revenue (a related party via SK ecoplant’s channel until July 2025), the top three ~68%; (3) the bottom line is still a GAAP net loss (-$87M FY25) once financing and JV equity-losses are counted, management steers attention to non-GAAP metrics, and there is a 2020 restatement in the history that argues for accounting scrutiny. The dominant issue is valuation: ~34x EV/revenue, ~91x book, the 95th percentile of Bloom’s own valuation history, and a Street mean target (~$223) that sits below the market price. The competitive advantage is real but partly cyclical — a SOFC manufacturing-scale lead (~100x the nearest pure-play) plus moderate post-install captivity, resting heavily on a temporary speed-to-power scarcity premium that the capital cycle will erode.
This memo takes no position and sets no price target (see Claude’s Take above for the single, fenced-off exception). It lays out the evidence on both sides and isolates the falsifiable swing factors.
2. Business Overview
What Bloom does. Bloom Energy designs, manufactures, sells, installs and services on-site, behind-the-meter electric power generation systems built on a proprietary high-temperature solid-oxide fuel cell (SOFC) platform. The flagship Bloom Energy Server converts natural gas, biogas, hydrogen, or blends into electricity through an electrochemical, non-combustion process — no flame, no moving parts (FACT, FY2025 10-K, Item 1). Because there is no combustion, the system emits near-zero NOx/SOx/particulates and achieves higher electrical efficiency than reciprocating engines or small gas turbines. The same solid-oxide platform (shared cell-printing, stack assemblies, supply chain and manufacturing) underpins the Bloom Electrolyzer, a high-temperature solid-oxide electrolyzer that splits water into hydrogen using less electricity than low-temperature PEM/alkaline units. As of 12/31/25 Bloom had Energy Servers at ~1,100 sites across nine countries; the U.S. is the largest market and South Korea (~682 MW deployed via SK ecoplant/SK eternix) the second (FACT, FY2025 10-K).
How it makes money — four revenue streams (FY2025, contracts with customers):
| Stream | FY2025 ($M) | YoY growth | % of revenue | Nature |
|---|---|---|---|---|
| Product | 1,531.3 | +41.1% | 76.5% | Non-recurring — Energy Server hardware |
| Installation | 204.1 | +66.8% | 10.2% | Non-recurring — site engineering / commissioning |
| Service (O&M) | 228.3 | +6.9% | 11.4% | Recurring — long-term O&M, 5–20 yr terms |
| Electricity | 60.4 | +14.2% | 3.0% | Recurring — PPA / lease offtake |
| Total (per 10-K MD&A) | 2,024.0 | +37.3% | 100.0% | (Headline reconciled revenue ~$2,001.6M; see note) |
(FACT, FY2025 10-K MD&A segment table. The 10-K MD&A reports total revenue of $2,024.0M; the EDGAR XBRL “contracts with customers” headline is $2,001.6M — a ~$22M recast/lease-line difference flagged as an Open Question. Use ~$2.0B as the round headline.)
The model is overwhelmingly a product-hardware business (~77% of revenue), not a recurring-revenue compounder. Service is the only meaningful recurring annuity (~11%) and is structurally tied to the installed base: every Server ships with telemetry and is monitored 24×7 from Remote Monitoring & Control Centers (U.S. + India), with O&M agreements running 5–20 years. Service margin reached ~18% in Q1’26 — the ninth straight profitable quarter — a slow-build annuity that lags product sales by years. Electricity (~3%) is a deliberately shrunk legacy of the older balance-sheet-heavy “Bloom Electrons” PPA model.
The financing/managed-services architecture is central and easy to misread. Most U.S. end customers prefer to pay for power, not buy hardware. So Bloom sells the Server to a financier or strategic partner (who owns the asset and monetizes tax credits) while the end customer signs a PPA, Capacity Agreement, or Lease for the output. Revenue concentration is therefore extreme: in FY2025, three customers/distributors accounted for ~43%, ~13%, and ~12% of total revenue (top three ~68% combined; the largest a related party — SK ecoplant — through July 10, 2025) (FACT, FY2025 10-K, Concentration-of-Risk note). This is partly a channel/financier concentration masking a more diversified end-customer base, but it is real counterparty and timing risk.
The ecosystem relationships are the growth engine and the financing scaffold:
- AEP (Nov-2024): supply agreement for up to 1 GW of SOFCs for AI data centers — at signing “the largest-ever commercial procurement of fuel cells”; converted to a $2.65B unconditional definitive purchase agreement (a portion of the option) in Jan-2026, matched to a 20-year offtake near Cheyenne, WY (FACT, AEP 8-K 2026-01-04).
- Brookfield (Oct-2025): financing framework of up to $5.0B over five years in an “AI Infrastructure Fund” for qualifying Bloom projects; first 55 MW US tranche (~$140M) (FACT, Brookfield/Bloom PR).
- SK ecoplant: 2018 partner; Korean assembly JV, ≥500 MW take-or-pay distribution commitment; ceased to be a related party July 10, 2025 (FACT, 10-K).
- Oracle “Project Jupiter” (Apr-2026): up to 2.45 GW islanded AI-factory power block in New Mexico that replaces previously planned gas turbines and diesel gensets with a 100% Bloom solution (FACT, Oracle/Bloom PR; Q1’26 call). Management states “well more than half” of current data-center backlog is from other hyperscalers/neoclouds/colos (management framing; treat as hypothesis — the relevant section rule 8).
Revenue recognition: Product and Installation at delivery/commissioning (point-in-time, lumpy, permitting-dependent); Service ratably over the term; Electricity over time as power is delivered. The lag between contract signing and product revenue (permitting, interconnection, customer construction) is a structural feature.
Verdict — Business Overview. Bloom is fundamentally a capital-equipment manufacturer of a differentiated, non-combustion on-site power product, wrapped in a financing apparatus (AEP, Brookfield, SK) that converts hardware sales into customer “power-as-a-service.” The recurring mix is thin (~14%) and the business is lumpy, project-driven, permitting-gated, and highly customer-concentrated (~68% top-three). It has only recently reached scale ($2.0B FY25, guided to $3.4–3.8B FY26). It is a real, differentiated product business hitting an inflection — a genuine technology platform attached to a lumpy, concentrated, project-finance-dependent revenue model.
3. Industry Dynamics
The market: firm, dispatchable on-site power. Bloom does not really compete in “fuel cells” — it competes against every source of always-on, behind-the-meter electricity: the utility grid, gas reciprocating engines (Cummins, Caterpillar), small/aeroderivative gas turbines and combined-cycle plants (GE Vernova, Siemens Energy, Mitsubishi Power), diesel/gas gensets, solar-plus-storage, and (prospectively) small modular reactors. The addressable market is the on-site slice of the broader power-generation pool, which is being reshaped by one dominant force.
The thesis driver — the AI data-center power crunch and grid-interconnection bottleneck. This is well-evidenced, not narrative:
- U.S. generator interconnection queues totaled ~2,300 GW at end-2024, with multi-year timelines (FACT, FY2025 10-K).
- Goldman Sachs forecasts global data-center electricity demand up ~160% by 2030 (external, 2025).
- Traditional OEMs are supply-constrained. GE Vernova ended 2025 with an ~80 GW gas-turbine backlog stretching toward 2029–30; new heavy-duty turbine lead times run ~3 years, some quotes 5–7 (FACT, Utility Dive / Power Engineering, 2025–26). The substitutes cannot deliver on the schedule AI demands. Bloom’s product arrives “this year or the next”; turbine orders placed today arrive “only in 2029 or later” (management, Q1’26 call — the turbine-backlog figure is externally confirmed).
Sizing the prize, and why the constraint is timing not dollars. A single large AI campus now contemplates 1–2.5 GW of dedicated power (Oracle’s Jupiter ceiling is 2.45 GW at one site). For scale: Bloom’s entire installed base after 25 years is ~2+ GW, and its current annual manufacturing capacity is ~5 GW. So the addressable near-term opportunity is not a question of whether the market is large enough — a handful of hyperscale campuses could absorb Bloom’s entire output for years — but of whether Bloom can manufacture and deploy fast enough to capture it before substitutes arrive. That reframes the industry question: the binding scarcity is deliverable megawatts on an AI timeline, and for the next ~2–3 years Bloom is one of the very few suppliers that can deliver them. The hyperscalers funding this — Amazon (~$200B), Google (~$175–185B), Microsoft, Meta, Oracle — are guiding to record FY26 capex, so the demand pool is, for now, both enormous and well-capitalized. The risk is not that the prize is too small; it is that the prize is tethered to a single, reflexive capex cycle that could digest or air-pocket.
Substitutes — pressure-tested:
- Gas turbines / combined-cycle: Lower $/kW at scale and a mature supply base, BUT 3–7 yr lead times, combustion emissions and air-permit friction, water use, noise, and redundancy needs. The binding constraint is availability and permitting speed, not cost.
- Diesel/gas gensets: Cheap, fast for backup, but dirty, noisy, low-efficiency, poor for continuous baseload — the very thing Oracle’s Jupiter explicitly designed out.
- Utility grid: Cheapest per-kWh default, but the interconnection queue is the bottleneck.
- Solar + storage: Intermittent; ~125x the land for equivalent output — impractical as primary baseload for space-constrained sites.
- SMRs: Promising but deployment is 2030s — not a near-term competitor.
SOFC / fuel-cell competitors:
- Plug Power (PEM): ~-$1.7B net loss FY25, deeply negative gross margins, CEO change Mar-2026 — financially distressed, not a stationary-baseload competitor.
- FuelCell Energy (MCFC): lower efficiency/durability than SOFC, sub-scale, negative gross margins.
- Doosan Fuel Cell / Ceres Power (licensee): the most credible emerging SOFC threat — Doosan began mass production at a 50 MW SOFC factory (Jul-2025), first commercial order just 9 MW (Dec-2025). The scale gap is enormous: Doosan’s entire SOFC plant is 50 MW vs. Bloom’s ~5 GW annual capacity — ~100x (FACT, Q1’26 call + external).
- Mitsubishi Power: large turbine OEM developing SOFC/hybrid; well-capitalized but turbine-centric and supply-constrained on turbines.
Regulation — a double-edged, fast-moving variable, net mildly favorable.
- OBBBA (2025) is a net positive for Bloom’s core product: for fuel-cell property beginning construction after 12/31/2025, OBBBA grants a flat 30% Section 48E ITC and removes the prior zero-GHG requirement, so natural-gas SOFCs now qualify (they previously did not under the IRA’s emissions-gated 48E) — expanding Bloom’s credit-eligible base. Offsets are minor: no domestic-content/energy-community bonus adders for fuel cells, and the the relevant sectionV hydrogen PTC terminates for construction after 12/31/2027 (FACT, 10-K; tax-counsel analyses).
- June-9-2026 court ruling: a federal judge struck down an IRS rule that would have made wind/solar credits harder to claim — a sector-sentiment tailwind, tangential to BE specifically (FACT, Benzinga 2026-06-09). Do not overweight.
- Interconnection / gas bans: some CA/Northeast municipalities ban new gas interconnections but frequently carve out non-combustion resources like Bloom.
Marathon capital-cycle read. High returns are visibly attracting capital — GE Vernova/Siemens racing to add turbine capacity, Doosan/Ceres entering SOFC, Bloom adding hundreds of MW/quarter. The supply lag is the protective moat of the moment: turbine additions are lumpy and years out, delaying the supply response that compresses returns. The risk is the late-boom setup — once turbine OEMs catch up (2028–30) and SOFC entrants scale, the scarcity premium compresses. The BE valuation (EV/Rev ~34x, beta 3.83) prices the boom as durable.
Verdict — Industry Dynamics. Structurally attractive right now, but cyclically charged and not durably defensible at the industry level. The demand surge is real, large, and corroborated (2,300 GW queue, 80 GW turbine backlog, ~160% demand growth to 2030); the supply-side bottleneck in substitutes is Bloom’s friend. But this is a capital-cycle boom: high returns are attracting capital across turbines and SOFC, demand is tied to a single hyper-cyclical end-market (AI capex), and ITC policy is a swing factor outside Bloom’s control. A good industry to be in for the next few years — but one whose attractiveness is supply-lag-dependent and mean-reverting, not a stable franchise pool.
4. Competitive Position
Greenwald taxonomy — test each candidate advantage:
1. Proprietary technology / IP (supply/cost advantage) — REAL but the weakest, most transient type. Bloom holds ~380 active U.S. utility patents + 183 pending, plus ~252 international + 416 pending (FACT, 10-K), and 25 years of applied materials know-how; it has cut cost, raised output, and extended fuel-cell life >2.5x since gen-1. SOFC’s intrinsic edge over rivals — higher electrical efficiency, no external reformer, fuel flexibility, non-combustion emissions — is genuine vs. PEM, MCFC, and PAFC. But Greenwald warns “in the long run everything is a toaster”: U.S. patents expire 2026–2044, and Ceres/Doosan prove the architecture is replicable by well-funded entrants. Technology + IP is a lead, not a fortress.
2. Economies of scale + (some) customer captivity — the strongest candidate, and Bloom’s best claim. Scale is a barrier only when paired with captivity, and it depends on share of the relevant market. In SOFC specifically, Bloom is dominant: ~5 GW of current annual manufacturing capacity (Fremont, CA + Newark, DE, “copy-exact,” adding hundreds of MW/quarter) versus Doosan’s entire 50 MW SOFC plant and FuelCell Energy’s sub-scale MCFC lines — a ~100x SOFC manufacturing-scale lead funding the cost-down and R&D that widen the gap. Captivity exists but is moderate: once a customer islands a multi-hundred-MW microgrid on 100% Bloom Servers (Oracle Jupiter), Bloom becomes the sole 24×7 service provider for a 5–20-year O&M life with proprietary telemetry. Caveat (Greenwald): “market growth is the enemy of scale advantages” — as the on-site-power market explodes and entrants pour in capacity, fixed costs shrink as a share of total and the scale edge erodes. The scale advantage is real in SOFC today but sits in a growing, contestable broader power market.
3. Speed-to-power / time-to-deploy — the real, present, but potentially temporary advantage. Bloom’s sharpest selling point and the basis for the Oracle win: energize “this year or the next” while turbine orders arrive “only in 2029 or later” — and the 80 GW / sold-out-to-2030 turbine backlog independently confirms the substitute constraint. Plus permitting ease (non-combustion → faster air permits, fewer gas-interconnection bans, less community resistance). Pressure-test: this advantage is a function of competitor supply scarcity, not an intrinsic Bloom barrier. It is strong through ~2028, then contestable as turbine OEMs work down backlogs (~2029–30), SOFC entrants scale, and interconnection reform eases the queue. The durable piece is manufacturing cadence; the scarcity premium is cyclical.
4. Switching costs / network effects — modest. Real switching costs exist post-install (sole-source O&M, telemetry, re-permitting). There are no network effects — one customer’s Bloom island does not make the next more valuable. Don’t overclaim.
Direct comparison, by the numbers:
| Company | Tech | Scale (annual) | FY2025 gross margin | Profitability |
|---|---|---|---|---|
| Bloom Energy | SOFC | ~5 GW capacity | 29.3% (28.1% FY24) | GAAP op. income +$73M FY25; +17% op. margin Q1’26 |
| Plug Power | PEM | sub-GW | negative (~ -55% Q1) | ~-$1.7B net loss FY25 |
| FuelCell Energy | MCFC | sub-scale | negative | chronic losses |
| Doosan / Ceres | SOFC (lic.) | 50 MW plant | early / royalty | pre-scale; first 9 MW order Dec-25 |
| GE Vernova / turbine OEMs | Gas turbine | GW-scale but sold out to 2030 | high (mature) | highly profitable, but can’t deliver fast |
(FACT, 10-K + Q1’26 call + external sources.) Bloom is the only profitable, scaled, non-combustion on-site-power pure-play — positive and rising gross margin (13.1%→29.3% over FY22–25) and positive GAAP operating income, while fuel-cell peers bleed cash and turbine OEMs can’t deliver on AI timelines.
Applying Greenwald’s formal tests. Two diagnostic tests sharpen the verdict. (1) Market-share stability: a genuine competitive advantage shows up as stable or rising share within a defined market, with low customer churn. In SOFC, Bloom’s share is overwhelmingly dominant and rising (it is taking share from turbines/diesel at the campus level, e.g., Oracle Jupiter), and post-install churn is structurally near-zero (sole-source 5–20-yr O&M). This test passes — within SOFC. It is indeterminate in the broader on-site-power market, where Bloom is a small share of total generation and the “market” itself is being redefined by the AI build-out. (2) Returns test: a moat should produce returns on capital persistently above the cost of capital. Here the evidence is too young — Bloom only crossed into GAAP operating profit in FY24 and is still GAAP-net-loss-making, so a multi-year above-cost-of-capital ROIC has not yet been demonstrated. The forward unit economics (~35% product gross margin, ~3% capex intensity) imply it will, but “imply” is not “proven.” Net: Bloom passes the share-stability test within its niche and is on track but unproven on the returns test — consistent with an emerging, not-yet-seasoned, franchise.
Can gas turbines/gensets do it cheaper? Yes — eventually, on $/kW at scale. The honest bear point: at steady-state, a combined-cycle plant beats Bloom on levelized cost, and once turbine supply normalizes the cost gap reasserts. Bloom’s answer is non-cost: schedule certainty, permitting, emissions, community acceptance, modularity. Those matter intensely while power is scarce and less once the grid/turbines catch up. Bloom’s durable edge is not “cheaper electrons” — it is “electrons available now, cleanly, where you can’t get them otherwise.”
Verdict — Competitive Position. A real but partly cyclical advantage — not yet a proven durable franchise. In Greenwald’s terms: a transient supply/technology advantage (SOFC IP, eroding) layered on a genuine economies-of-scale-in-SOFC advantage (~100x the nearest pure-play) combined with moderate post-install captivity (sole-source 5–20 yr O&M) — the most durable leg — but current outsized returns rest heavily on a temporary speed-to-power scarcity premium the capital cycle will erode. The Oracle 100%-Bloom win and the financial gap vs. Plug/FuelCell Energy are strong evidence Bloom has separated from the fuel-cell pack and reached escape-velocity scale. The open question is whether Bloom converts today’s scarcity lead into a defended scale-plus-captivity moat before turbine OEMs and SOFC entrants close the time-to-power gap (~2028–30). Durable advantage in SOFC; contestable advantage in on-site power broadly. Not a crowded commodity, but not yet an unassailable franchise.
5. Growth History and Forward Opportunities
The historical record: real but, until 2025, unspectacular. Bloom is an all-organic grower — no acquisitions of consequence; the entire installed fleet was built and sold by Bloom. Revenue moved $1,135M (FY22) → $1,269M (FY23, +12%) → $1,441M (FY24, +14%) → $2,002M (FY25, +37%). For a decade the story was “good technology, perennially unprofitable, lumpy bookings.” Two facts matter for judging growth quality:
- A 100% service attach rate. Every product sale carries a 10–15-year service contract. Service backlog is ~$14B and Service hit ~18–20% gross margin — converting an episodic equipment business into a growing annuity (INTERPRETATION: the most underappreciated quality attribute — recurring, higher-margin, contractually attached revenue that compounds with every MW shipped).
- Book-and-ship is now a “significant double-digit %” of revenue. Bloom delivered a hyperscale order in ~55 days against a 90-day commitment — the operational core of the time-to-power pitch.
The inflection: Q1’26 +130% YoY. Q1’26 revenue was $751.1M, +130.4% YoY — the first >100% quarter in Bloom’s public history; Product $653.3M (all-time high), Service $61.9M (+15.6%). The driver is data-center on-site power. Management disclosed that “well more than half of our current data-center backlog comes from other hyperscalers, neoclouds and colocation providers” beyond Oracle, and that the backlog “includes half a dozen hyperscale and neocloud end customers compared to just one a year ago” (Q1’26 / Q4’25 calls). This diversification matters against the bubble critique (FACT per management; OPEN QUESTION: names beyond Oracle/AEP are undisclosed, so the “half-dozen” is not yet independently verifiable).
Backlog & bookings — the contracted spine vs. the aspirational TAM.
- Contracted / hard: Product backlog ~$6B (+140% YoY) and service backlog ~$14B (Q4’25). The 10-K notes product backlog “reflects anticipated ITC and other tax incentives” — i.e., the headline figure is partly grossed-up by expected tax credits, not pure equipment revenue. Treat $6B as directional, not a recognition schedule. AEP converted to a $2.65B unconditional purchase (the units are taken regardless of offtake) in Jan-2026.
- Aspirational / TAM (discount heavily): the Oracle “up to 2.45 GW” and AEP “up to 1 GW” figures are framework maxima; only a fraction is near-term contracted backlog. Management explicitly declined long-term (2030) guidance and pushed back on a supplier’s 30%-CAGR-to-2030 claim (“nobody has visibility past [6 months]”) — honest, but it means the multi-year ramp underpinning the ~14x stock move is ununderwritten by the company itself.
FY2026 guidance — raised materially, twice:
| Metric (non-GAAP) | FY25 actual | FY26 guide (Feb-5) | FY26 guide RAISED (Apr-28) |
|---|---|---|---|
| Revenue | $2,002M | $3,100–3,300M | $3,400–3,800M (~80% mid) |
| Gross margin | ~30.3% | ~32% | ~34% |
| Operating income | $221M | $425–475M | $600–750M |
| Diluted EPS | — | — | $1.85–2.25 |
The April raise lifted the low end above the prior high end — a genuine step-change (“Q2 should be at least as good as Q1”). These are non-GAAP; FY25 GAAP was a -$87M net loss, so the GAAP/non-GAAP gap (SBC, financing/JV items) remains wide.
Forward opportunities by vertical: data centers (the engine; 800V-DC-native product is a forward differentiator as AI racks move to 800V); C&I (backlog +135% YoY; ~2/3 repeat customers; geographic shift from >80% CA/Northeast to >80% lower-power-cost states — evidence the product now wins on economics, not regulatory arbitrage); utilities (AEP rate-base template); international (US ~81% of FY25 revenue; Korea #2; Europe/India small and “a few years” out); hydrogen/electrolyzer (de-prioritized by the relevant sectionV termination — now a minor optional leg).
Verdict — Growth. High-quality growth, with two caveats. It is organic; carries a 100% service attach rate that converts each MW into a 10–15-yr annuity; margins are expanding with volume (op margin 17.3% Q1’26 vs. ~5% a year prior); demand is diversified across a half-dozen hyperscalers plus a broad C&I base; and the move into low-power-cost states shows the product wins on economics now. The caveats: (1) the headline backlog blends hard POs, frameworks, reservations, and ITC gross-ups — truly contracted near-term revenue is a fraction of the press-release TAM; (2) demand durability is unproven through a cycle — the inflection is ~5 quarters old and rides on hyperscaler capex. Growth is high-quality given the demand; the open question is the demand’s persistence, not Bloom’s ability to convert it.
6. Financial Quality
Five-year financial summary (the inflection in one table):
| Metric ($M unless noted) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | 1,135.3 | 1,268.8 | 1,441.4 | 2,001.6 |
| Gross profit | 148.3 | 197.8 | 404.6 | 587.4 |
| Gross margin | 13.1% | 15.6% | 28.1% | 29.3% |
| Operating income (GAAP) | (261.0) | (208.9) | 22.9 | 72.8 |
| Net income (GAAP) | (301.7) | (302.1) | ~(40) | (87.1) |
| Operating cash flow | ~(192) | (372.5) | 92.0 | 113.9 |
| Capex | ~(45) | (83.7) | (58.9) | (56.8) |
| Stock-based comp | ~(60) | ~(75) | 83.0 | 145.0 |
| Cash & equivalents (year-end) | 348.5 | 664.6 | 802.9 | 2,454.1 |
| Diluted wtd-avg shares (M) | ~178 | 212.7 | 227.4 | 240.4 |
(FACT, EDGAR XBRL + FY2025 10-K; figures marked “~” are approximate/derived. The table reads cleanly left-to-right: revenue compounding, gross margin doubling, operating income crossing zero in FY24, and operating cash flow swinging ~$486M from -$372M to +$114M between FY23 and FY25 — all while capex stayed flat near $57M. This is the quantitative spine of the bull case and the proximate reason the multiple expanded.)
Revenue composition. ~76% Product (+41% YoY), ~10% Installation (a near-cost pass-through), ~11% Service (the strategically important recurring book), ~3% Electricity (a shrinking-by-design legacy). The genuinely recurring annuity is ~14% of revenue. This is not a software-like recurring model; it is a capital-equipment manufacturer with an attached service tail, and revenue durability rests on a continuing order pipeline, not contracted recurring cash flows. Customer concentration is severe and worsening — three customers at ~43%/13%/12% (the 43% a related party). A single counterparty at 43% of revenue is an acute quality red flag (OPEN QUESTION: how much is true end-demand vs. distributor channel-fill / take-or-pay minimums?).
Margin trajectory and drivers. GAAP gross margin: 13.1% (FY22) → 15.6% (FY23) → 28.1% (FY24) → ~29% (FY25); the step-change from ~16% to ~28% between FY23 and FY24 is the single most important financial event in the story. GAAP operating income inflected -$209M (FY23) → +$23M (FY24) → +$73M (FY25). Drivers: per-kW cost-down (“double-digit cost reductions year after year”; product GM ~35%), manufacturing-overhead absorption / scale, and mix (Product rising as a share of total). Management guides on non-GAAP gross margin (32%→34% for 2026), which excludes ~$24M of SBC in cost of revenue — so the headline margins the market anchors on flatter the GAAP reality by 2–4 points.
The Service segment has turned. FY2024 Service was a small loss (-$1.4M, -0.7% GM); FY2025 flipped to +$22.9M gross profit (10.0% GM) as stack durability improved, reaching ~18% in Q1’26. This is the most credible “economics-improve-with-scale” data point in the file and a meaningful de-risking (it removes a chronic drag and the source of the 2020 restatement). Caveat: Service is still only ~11% of revenue and the margin is thin.
Free cash flow / cash-burn inflection.
| Period | Operating cash flow | Capex | Free cash flow (approx) |
|---|---|---|---|
| FY2023 | (372.5)M | (83.7)M | (456)M |
| FY2024 | +92.0M | (58.9)M | +33M |
| FY2025 | +113.9M | (56.8)M | +57M |
| Q1’26 | +73.6M | n/a | positive (record Q1) |
A decisive funding-model inflection: from burning ~$370–450M/yr through 2023 to generating positive operating and free cash flow in FY24–FY25, with Q1’26 the first-ever cash-positive Q1. Capex is strikingly low (~$57M, ~3% of revenue) — the “low capital intensity / copy-exact” claim is supported by the numbers. The business no longer requires external capital to fund operations; the 2025 raises were opportunistic balance-sheet fortification, not survival financing.
SBC and dilution. SBC: $83.0M (FY24) → $145.0M (FY25), +75% — ~7% of revenue and roughly double FY25 operating income; the FY25 increase was driven by ~+$55M of PSUs/RSUs including the CEO’s Dec-2024 mega-grant. Diluted weighted-average shares: 212.7M (FY23) → 227.4M (FY24) → 240.4M (FY25); shares outstanding ~284M now, roughly doubled from the IPO-era ~130M. Per-share economics meaningfully lag enterprise economics.
ROIC / ROE — not meaningful. With a FY25 net loss (-$87M, -$0.37 EPS) and book value ~$3.24/share against a ~$259 price (~80x book), conventional ROE/ROIC are not meaningful. Bloom is valued entirely on a forward operating-income/FCF ramp. The relevant forward test is whether incremental product gross margin (~35%) minus opex growth produces rising operating returns as revenue scales — the Q1’26 op margin of 17.3% (+1,300 bps YoY) is the early evidence.
Balance sheet. Cash & equivalents $2,454M (vs. $803M FY24), driven by the Q4’25 0% convertible. Recourse debt ~$2,614M (more than doubled), all convertible; non-recourse debt ~$0 (legacy PPA-entity debt wound down). Net debt ≈ -$160M (roughly net-neutral), but the debt is 0%-coupon and 3.0%-coupon convertibles — light cash-interest burden. Convertible stack: $2,500M 0% Notes due Nov-2030 (conversion ~$195); ~$518M 3.0% Notes due 2029; $632.5M 3.0% Notes due 2028; capped calls purchased on several tranches. Runway is effectively unlimited. The catch: a large conversion-dilution overhang — at $259 vs. strikes well below, tranches are in the money, so the ~284M basic count understates fully-diluted shares (OPEN QUESTION to quantify).
Unit economics — the heart of the bull case, quantified. The extractable unit economics are genuinely attractive and are what separate Bloom from every other fuel-cell name. Product gross profit was ~$538M on ~$1,531M of product revenue in FY25 — a ~35% product gross margin — and this margin has been rising with volume (the cost-down roadmap delivers “double-digit” per-kW reductions annually). Against that, the capital required to build the ~5 GW of annual manufacturing capacity is being added for capex of only ~$57M/yr (~3% of revenue), i.e., Bloom expands a gigawatt of capacity for “materially less capital than industrial-era players.” The implication: each incremental gigawatt shipped at ~35% product gross margin drops a large slug of gross-profit dollars onto a nearly-fixed manufacturing and R&D base, so operating margin should expand faster than gross margin as utilization rises — exactly what the Q1’26 print (17.3% op margin, +1,300 bps YoY) begins to show. The bear’s counter is that ~35% is a scarcity-window margin: it reflects pricing power Bloom holds only while power is scarce, and a normalized SOFC margin in a contested 2029-era market could be materially lower. Both can be true — the current unit economics are real and improving, but they are not yet proven through a full competitive cycle.
Electrolyzer / hydrogen optionality — a small, de-prioritized call option. The same SOFC platform underpins a high-temperature solid-oxide electrolyzer (SOEC) that the bull case frames as a second TAM. We weight it lightly: OBBBA terminates the the relevant sectionV hydrogen production credit for projects beginning construction after 12/31/2027, and management has explicitly de-prioritized hydrogen relative to data-center power. It is a genuine free option embedded in the platform, but it is not a thesis pillar and should be valued near zero in a base case.
Net income bridge — why GAAP is still a loss. GAAP operating income was +$72.8M but the bottom line was -$87.1M (-$0.37/sh), dragged below zero by interest expense ($53.9M), a $32.3M loss on early debt extinguishment, and $40.4M of equity-in-loss of unconsolidated JVs (the PPA “Fund” entities). BE is GAAP-operating-profitable but not yet GAAP-net-profitable, and the gap is financing/JV costs.
Verdict — Financial Quality. Economics DO improve with scale — and the evidence has shifted from promise to proof over 24 months. Gross margin doubled, the chronically loss-making Service segment turned profitable, operating income inflected positive, and operating/free cash flow turned firmly positive on strikingly low capex. The business has graduated from a cash-incinerating science project to a scaling, FCF-positive manufacturer. But three caveats keep this short of “high quality”: (1) ~43% single-(related-party-)customer concentration; (2) the bottom line is still a GAAP net loss once financing/JV costs count, and management steers attention to non-GAAP; (3) SBC at ~7% of revenue plus convertible overhang means per-share economics lag enterprise economics. The direction is clearly favorable; the durability and per-share translation are not yet proven.
7. Capital Allocation
Issuance and dilution. Bloom financed two decades of pre-profit operations almost entirely by issuing securities. Share count grew from ~130M (IPO, 2018) to ~284M today — ~2.2x — through equity raises, ATM programs, the SK equity investment, employee SBC, and in-the-money convertible conversions. Convertible history: 2023 $632.5M 3.0% Notes; 2024 $402.5M 3.0% Notes (+ capped calls); 2025 $2,500M 0% Notes (net $2,440M) — the transformational Q4’25 raise — plus a $112.8M-for-$115.7M debt exchange booking a $32.3M extinguishment loss.
The 2025 raise and use of proceeds. The $2.5B 0% convertible is the defining event: proceeds toward manufacturing-capacity expansion (toward 5 GW), working capital for the production ramp (inventory rose to ~$643M; AR to ~$372M), capped-call purchases, and balance-sheet fortification. A 0%-coupon, five-year instrument raised into a soaring stock is, on cost-of-capital terms, shrewd financing — effectively free money if it never converts, and if it converts it does so at an elevated reference price (~$195). The risk is purely the dilution if the stock stays above the strike.
R&D / S&M intensity; no buyback or dividend. R&D ~$186M FY25 (~9% of revenue, up from ~$149M FY24) — appropriate for a technology-differentiated manufacturer and the engine of the cost-down roadmap. S&M scaled sharply (land-grab into hyperscalers). No dividend, no buyback — correct for a hypergrowth company still consuming working capital and not yet GAAP-net-profitable; reinvestment at ~35% product gross margin and low capex is the right call.
SK ecoplant & JVs; M&A. SK provided early capital, Korean manufacturing localization, and captive offtake (≥500 MW take-or-pay) — value-additive — but the related-party revenue (part of the 43% concentration) and the PPA “Fund” JV losses ($40.4M equity-in-loss FY25; $36.5M contributed) are governance/quality flags. SK sold below the related-party threshold July 2025 (2.5% stake). M&A: essentially none — organic growth, a reasonable low-risk posture for a hardware scaler.
Insider behavior & comp. From the DEF 14A (filed 2026-04-08): CEO KR Sridhar’s FY25 SCT total comp was $3.5M (salary + 200%-of-target cash bonus, no new equity grant in 2025) vs. $45.0M in FY24 (inflated by a ~$42.4M Dec-2024 multi-year PSU mega-grant). “Compensation Actually Paid” for 2025 was ~$416M under SEC CAP methodology — mechanically driven by the 291% stock surge revaluing unvested awards. PSUs earned 300% of target; the cash bonus paid at 200%. Incentive metrics are operationally sound — the cash bonus is 50% non-GAAP operating income + 50% total revenue; PSUs are annual product-revenue-growth + adjusted-product-gross-margin — i.e., management is paid on the levers that drive intrinsic value. The negatives: extreme magnitude (a ~$416M CAP year, 300%/200% payouts), and the metrics are non-GAAP, excluding the very SBC being granted (circular). Insider transactions (Form 4, Apr–Jun 2026): consistent net selling by officers/directors into the spike (Chambers, Soderberg, Bush, Joshi, Chitoori at $204–$298), all via 10b5-1 plans or vesting; CEO filings are option exercises (code M), not open-market sales/buys; routine director RSU grants (code A); zero open-market purchases (code P) anywhere. Net read: mildly cautious — heavy selling, no conviction buying — but plan-driven post-spike diversification is weak evidence, not a red flag.
Marathon capital-cycle lens. Bloom is raising large capital into a white-hot end market at a peak valuation to fund rapid supply expansion — the asset-growth + capital-raising-into-euphoria signature Marathon flags as the setup for disappointing forward returns if demand normalizes. The mitigant: capex per GW is low and the 0% converts are cheap, so Bloom can add supply without a classic debt-fueled overbuild. The bull rebuttal: demand is genuinely supply-constrained for years, so the cycle is early, not late.
Verdict — Capital Allocation. Mostly intelligent, with real governance caveats — “good allocation, rich pay.” Management raised cheap (0%/3%) convertible capital opportunistically at a peak valuation and is deploying it into low-capital-intensity capacity at ~35% product gross margin — a defensible reinvest-over-distribute choice. R&D intensity (~9%) is appropriate; the no-buyback/no-dividend stance is correct; comp metrics are anchored to the right drivers. The caveats temper the verdict: ~2.2x cumulative dilution plus a large convertible overhang; eye-watering pay magnitude on non-GAAP metrics that exclude the SBC being granted; related-party SK revenue and $40M JV losses; and the Marathon flag of capital-raising into euphoria.
8. Changes and Headwinds — Last Two Years
The strategic pivot to data-center on-site power is the defining change. Through ~2023 Bloom was a C&I/utility and hydrogen-aspirant story; the AEP gigawatt agreement (Nov-2024) was the hinge. Management reframed the value proposition around time-to-power and community acceptance, and shifted manufacturing from lumpy one-off additions to “continuous” hundreds-of-MW-per-quarter expansion toward 5 GW. This strengthens the thesis (the demand pool’s binding constraint matches Bloom’s core differentiator) but concentrates the story on a single, capex-cycle-sensitive end market.
Three landmark relationships: AEP (1 GW option → $2.65B definitive, Jan-2026, validating the utility rate-base channel); Oracle Project Jupiter (up to 2.45 GW, 100% Bloom, Apr-2026, plus a market-priced warrant/strategic-partnership component — final terms undisclosed as of the Q1’26 call, a modest dilution item to track); Brookfield (up to $5B financing vehicle, Oct-2025, a demand enabler). Collectively these moved Bloom from “interesting technology” to “anchor supplier to named Tier-1 AI buyers.” Strengthens thesis.
Governance / charter changes (correcting a common misread). At the May-21-2026 annual meeting, shareholders approved charter amendments to (i) provide officer exculpation and (ii) eliminate inoperative provisions including legacy Class B language — effective May 26, 2026. This was NOT a board declassification. Officer exculpation is mildly shareholder-negative at the margin but is now boilerplate post-2022 Delaware law; the Class B cleanup is housekeeping. Net: governance-neutral.
Leadership change — new CFO. Simon Edwards joined as CFO ~mid-April 2026 (his first call was Q1’26), succeeding an Acting PFO chain. He brings AI-adjacent/scaling experience (Groq). Sensible at the inflection, but a brand-new CFO at a hypergrowth, related-party-heavy, complex-accounting company is an execution-watch item.
Capital raises / balance sheet. The $2.2B (upsized; ~$2.5B with greenshoe) 0% convertible due 2030 priced Oct-2025 at a ~$195 conversion price, fortifying the balance sheet to ~$2.5B cash ahead of the capacity ramp. Cheap capital; deferred-but-real dilution if the stock stays above conversion.
SK ecoplant — related-party status changed but concentration remains. SK ceased being a related party July 10, 2025 (sold to ~2.5%), yet SK-related sales were still ~43% of FY25 revenue (and ~55% of Q3’25). The de-designation removes governance optics but not the concentration risk, and SK’s continued selling is a float overhang.
Policy / regulatory — net POSITIVE for fuel cells (correcting common misread). OBBBA (2025) added natural-gas fuel cells to the 30% Section 48E ITC through 2033 by removing the zero-GHG requirement — expanding Bloom’s credit-eligible base; the offsets (no bonus adders, the relevant sectionV hydrogen PTC termination after 2027) are minor for BE. The June-9-2026 court ruling on wind/solar credits is a tangential sector tailwind. Tariffs/supply chain are a genuine input-cost headwind but historically absorbed via cost-downs.
Verdict — Changes and Headwinds. On balance, STRENGTHEN the thesis. A strategic pivot that aligns Bloom’s core edge (speed) with the largest demand pool of the decade; three Tier-1 anchor relationships validating the product across utility, hyperscaler, and financing channels; a cheap balance-sheet fortification; and — contrary to widespread assumption — an improved policy backdrop for natural-gas fuel cells. The offsetting weakenings are real but secondary: ~43% concentration, deferred convertible dilution, an undisclosed Oracle warrant overhang, a brand-new CFO, and an SK float overhang. None breaks the thesis; together they place the risk in demand durability and concentration, not in the change set itself.
9. Risk Analysis
| # | Risk | Likelihood | Impact | Evidence basis |
|---|---|---|---|---|
| 1 | Valuation de-rating (multiple compresses toward peers) | High | High | 95th-pct own-history valuation; ~34x EV/Rev vs. peer median ~5x; Street mean target below price |
| 2 | AI-capex air-pocket / demand normalization | Med | High | Revenue tethered to hyperscaler capex; inflection only ~5 quarters old; beta 3.83 amplifies any pullback |
| 3 | Turbine / genset substitution as supply catches up (~2028–30) | Med | High | Bloom’s edge is availability not cost; 80 GW turbine backlog will be worked down; Marathon mean-reversion |
| 4 | Customer concentration (~43% top customer; ~68% top three) | High | High | FY25 10-K concentration note; related-party SK channel; take-or-pay timing risk |
| 5 | ITC / policy reversal (48E narrowing, “country-of-concern” rules) | Med | High | Project economics lean on the credit; OBBBA excluded fuel cells from bonus adders; Treasury reinterpretation risk |
| 6 | Dilution (SBC ~$145M/yr; convertible conversion overhang) | High | Med | Share count ~2.2x since IPO; in-the-money $195 converts; SBC ~7% of revenue |
| 7 | Execution / capacity ramp (toward 5 GW; new CFO at inflection) | Med | Med | Hundreds of MW/quarter expansion; brand-new CFO; permitting/interconnection timing |
| 8 | Accounting / non-GAAP reliance (2020 restatement legacy) | Low–Med | Med–High | 2020 PPA-accounting restatement; heavy non-GAAP guidance & comp; related-party revenue; PPA “Fund” JV losses |
| 9 | Key-person (founder-CEO KR Sridhar) | Low | Med | Founder-led 25 years; concentrated strategic vision |
| 10 | Fleet reliability / warranty (stack durability surprise) | Low–Med | Med | Service just turned profitable; a reliability surprise could reverse the Service margin and re-open warranty risk |
| 11 | Liquidity / financing | Low | Low | ~$2.45B cash, FCF-positive, net-neutral debt — no longer a going-concern story |
Catastrophic-loss / total-loss assessment. A total loss is low-probability: the balance sheet is strong (~$2.45B cash, FCF-positive, cheap convertible debt) and the technology/order book is real. The realistic catastrophic-to-capital scenario is not insolvency but valuation collapse — a stock at ~34x revenue that de-rates toward even a generous high-growth-industrial multiple loses the majority of its value even if revenue keeps growing (see the the relevant section bear case, ~-90%). The dominant risk here is price, not solvency.
10. Valuation Discussion — Embedded Expectations
No price target; valuation is framed strictly as embedded expectations and scenarios.
A price detached from every conventional anchor. At $259.61 (2026-06-09) on ~284.4M shares, equity is ~$82.5B; netting ~$2.45B cash against ~$2.6B recourse converts yields EV ≈ $84.0B (net debt roughly neutral). Against ~$2.45B TTM revenue:
| Multiple | BE | What it says |
|---|---|---|
| EV / Revenue (TTM) | ~34.3x | The only multiple that is even interpretable |
| EV / Gross Profit (TTM) | ~115x | ~$84B EV ÷ ~$718M TTM gross profit (derived) |
| Price / Sales (TTM) | ~28.1x | Richer than any scaled hardware peer |
| Price / Book | ~90.7x | Book ~$3.24/sh — essentially no asset backing |
| Forward P/E (consensus) | ~143x | On FY26 consensus EPS ~$2.13 (non-GAAP) |
| EV / EBITDA (TTM) | ~745x | Meaningless — near-zero denominator |
Most of these are meaningless, stated plainly. BE is not GAAP-net-profitable (FY25 -$87M loss), so P/E is an artifact of consensus forward estimates, EV/EBITDA at 745x is noise, and P/B at ~91x is uninformative (asset-light, ~3% capex intensity). That leaves EV/Revenue (~34x) and EV/Gross-Profit (~115x), plus a forward EV/EBIT read against the consensus operating-income ramp. The public market-data aggregator puts BE’s composite valuation at the 95th percentile of its own ~10-year history (P/S 99th, P/B 91st) — richer than the 2021 clean-energy bubble peak.
Peer context — a category of one. BE has no clean peer; it is priced as an AI-infrastructure growth story:
| Company | P/S (TTM) | EV/EBITDA | Fwd P/E | Rev growth | Profitability |
|---|---|---|---|---|---|
| Bloom Energy | ~28x | ~745x | ~143x | +130% Q1 | GAAP net loss; +17% op margin Q1 |
| GE Vernova (GEV) | 6.0x | 71x | 36x | +16% | Profitable; ~80 GW backlog |
| Eaton (ETN) | 5.1x | 28x | 24x | +17% | Profitable |
| Vertiv (VRT) | 9.9x | 47x | 32x | +30% | Profitable; DC power/cooling |
| Quanta (PWR) | 3.2x | 41x | 40x | +26% | Profitable |
| Generac (GNRC) | 3.3x | 31x | 22x | +12% | Profitable |
| nVent (NVT) | 5.8x | 30x | 28x | +54% | Profitable |
| Plug Power (PLUG) | 5.5x | neg. | neg. | +22% | ~-$1.7B net loss FY25 |
Even the richest profitable electrification peer (Vertiv, ~10x sales) trades at roughly one-third of BE’s P/S while growing 30%. A multiple 5–9x the peer median on sales demands the growth be both durable and margin-accretive for many years.
Embedded-expectations / reverse-DCF sketch (all INTERPRETATION/ASSUMPTION). Anchor on a defensible “mature” valuation and work backward. If by ~2030 the market values BE at ~25x EBIT (generous), supporting today’s ~$84B EV at a ~10% required return implies a 2030 EV ≈ $135B, i.e., ~$5.4B of 2030 EBIT. At a mature ~20% operating margin (roughly double FY25’s GAAP level), that requires ~$27B of revenue by 2030 — a ~$2.0B → ~$27B build, ~68% CAGR for five years. At a more conservative 15x EBIT exit, the bar rises to ~$45B revenue (~86% CAGR); at a generous permanent 35x, it eases to ~$19.5B (~58% CAGR). The embedded bet: roughly 55–85% revenue CAGR through 2030 and a doubling of operating margin to ~20% and a retained premium (15–35x EBIT) multiple — with zero margin of safety.
Is the consensus EPS ramp ($2.13 → $4.32) credible? Three reasons for skepticism: (1) these are non-GAAP/Street-adjusted figures (GAAP FY25 was a loss); (2) the FY27 doubling assumes flawless operating leverage on ~50%+ revenue growth with no ITC disruption or margin give-back; (3) rising share count plus the convertible overhang means per-share growth lags enterprise growth. Notably, the Street mean target (~$223) sits below the current price, with a ~3x bull-bear spread (Jefferies $97 Sell to Susquehanna $293) — when the consensus target is below the price and dispersion is that wide, the market is momentum-led, with sell-side fundamentals lagging the tape.
Scenario analysis (2030 endpoints; ~300M fully-diluted shares; defensible forward EV multiple; NOT a price target):
| Scenario | 2030 Revenue | Rev CAGR | GAAP op margin | 2030 EBIT | Exit mult. | Implied EV | Implied equity/sh |
|---|---|---|---|---|---|---|---|
| Bear | ~$6B | ~25% | ~10% | ~$0.6B | 12x EBIT | ~$7.2B | ~$24/sh |
| Base | ~$14B | ~48% | ~16% | ~$2.2B | 18x EBIT | ~$40B | ~$135/sh |
| Bull | ~$27B | ~68% | ~20% | ~$5.4B | 25x EBIT | ~$135B | ~$455/sh |
- Bear (~$24/sh, ~-90%): AI-capex normalizes, turbine/genset supply catches up by 2028–30 and re-takes cost-advantaged baseload, ITC narrows, scarcity premium collapses to a mid-cycle hardware multiple. Revenue still grows (25% CAGR) but multiple compression is brutal. The capital-cycle mean-reversion case.
- Base (~$135/sh, ~half spot): strong-but-decelerating ~48% CAGR to ~$14B, mid-teens margins, premium-industrial 18x EBIT. Even this good outcome implies the stock is ~2x its base-case worth today.
- Bull (~$455/sh, ~+75%): the full embedded case — ~68% CAGR, ~20% margin, 25x EBIT.
The asymmetry is unfavorable at $260: the distance to the bear case (~-90%) dwarfs the distance to the bull (~+75%), and the base case sits ~50% below spot. The stock is priced for the bull scenario to be the base case.
Verdict — Valuation. The price embeds a near-flawless, half-decade hyper-growth-plus-margin-inflection scenario with essentially no margin of safety. Only EV/Revenue and EV/Gross-Profit are interpretable; P/E, P/B and EV/EBITDA are artifacts of a near-zero/negative GAAP bottom line. At ~$84B EV the market underwrites ~55–85% revenue CAGR through 2030 and a doubling of operating margin to ~20% — against a business that is GAAP-loss-making, ~43% related-party-concentrated, ITC-dependent, and selling into a single hyper-cyclical end-market. The own-history 95th-percentile valuation and the Street mean target below the price both flag that fundamentals are lagging momentum. A great-growth-story / wrong-margin-of-safety setup: the operational inflection is real, but the price has already capitalized the bull case.
11. Variant Perception
Consensus belief. Bloom is the structural winner in on-site, behind-the-meter AI data-center power: the grid can’t deliver (2,300 GW queue), turbines are sold out to 2030, and Bloom can energize “this year or the next,” so hyperscalers are standardizing on Bloom. Margins are inflecting, cash flow has turned positive, and profitability is “finally arriving” (consensus EPS $2.13 FY26 → $4.32 FY27). The stock is a momentum proxy for AI-infrastructure capex.
Strongest bull case. (1) Speed-to-power as a structural moat while the bottleneck lasts — pricing power no cost comparison can dislodge. (2) A marquee, multi-GW pipeline (Oracle 2.45 GW, AEP up to 1 GW, Brookfield up to $5B) that de-risks the ramp. (3) Operating leverage that is visible, not promised (op margin +1,300 bps YoY to 17.3%; product GM ~35%; Service profitable nine quarters; capex ~3% of revenue). (4) Electrolyzer optionality as a barely-capitalized second TAM. (5) A restored policy tailwind (OBBBA 30% 48E ITC for natural-gas fuel cells through 2033).
Strongest bear case. (1) Extreme valuation / no margin of safety (95th-pct own-history; base case ~50% below spot). (2) ~43% related-party/single-counterparty concentration; top three ~68%. (3) Turbine/genset substitution as supply catches up ~2028–30 (Bloom’s edge is availability, not cost). (4) ITC dependence (any narrowing or “country-of-concern” reinterpretation hits demand). (5) Dilution (~2.2x since IPO; SBC ~7% of revenue; in-the-money convertible overhang). (6) Cyclical AI-capex concentration + beta 3.83 — a high-octane momentum vehicle, not a defensive compounder.
The 3–5 assumptions that matter most: (1) durability of the AI-power demand wave (multi-year secular build vs. 2024–27 capex spike); (2) durability of the speed-to-power advantage after turbine/SOFC supply catches up; (3) margin trajectory (does GAAP op margin reach ~20% or stall in the low teens); (4) ITC continuity through the decade; (5) genuine concentration de-risking vs. channel-fill.
What would falsify each side. Falsifies the bull: a hyperscaler order pause/cancellation or guided revenue deceleration below ~40%; product gross margin rolling below ~32%; a credible turbine-OEM capacity announcement collapsing 2028 lead times; an adverse ITC reinterpretation; or evidence the “diversified backlog” is concentrated channel-fill. Falsifies the bear: sustained >60% revenue growth with expanding GAAP margins for several more quarters; the customer base demonstrably broadening (multiple named Tier-1 hyperscalers each <15% of revenue); a clean GAAP-net-profit inflection; and turbine lead times staying long through 2029.
Short interest as a signal. Short interest is ~11.7% of float and rising (23.2M → 29.0M shares MoM). For an ~$82B-cap stock that is a substantial, conviction short — a genuine two-sided battleground. A rising short into a rising price creates squeeze risk on any positive surprise and signals sophisticated capital views the valuation as unsustainable. The 11.7% short, the ~3x analyst target spread, and the mean target below spot together describe a momentum-and-flow-driven price with deeply divided fundamental opinion.
Verdict — Variant Perception. Consensus owns the direction and is almost certainly right that the operational inflection is real. The variant question is not whether Bloom is a good business — it is whether a good business priced for a flawless decade is a good investment. The bear’s edge is the capital-cycle insight (the scarcity premium is competitor-supply-dependent and mean-reverting) plus the unforgiving math (base case ~50% below spot). The bull’s edge is that the bottleneck is real now and squeeze dynamics can keep momentum self-reinforcing past fair value. The decisive, falsifiable swing factor is what happens to the speed-to-power premium when turbine/SOFC supply normalizes around 2028–2030.
12. Fact vs. Interpretation Table
| # | Claim | Type | Basis |
|---|---|---|---|
| 1 | FY25 revenue ~$2.0B (+37%); Q1’26 +130% YoY | Fact | EDGAR XBRL; 10-K MD&A; Q1’26 call |
| 2 | GAAP gross margin 13%→29% (FY22→FY25); op income inflected positive FY24 | Fact | EDGAR GrossProfit / OperatingIncomeLoss |
| 3 | FY25 GAAP net loss -$87.1M (-$0.37/sh) | Fact | FY2025 10-K statement of operations |
| 4 | Operating cash flow turned positive (+$114M FY25); capex ~3% of revenue | Fact | 10-K cash-flow statement |
| 5 | Top customer ~43% of FY25 revenue (related party); top three ~68% | Fact | FY2025 10-K concentration note |
| 6 | The Service annuity makes growth “high quality” | Interpretation | Service margin turn + 100% attach rate; weighed vs. thin recurring mix |
| 7 | Speed-to-power is a durable moat | Interpretation | True now (turbine backlog confirmed); cyclical, supply-dependent |
| 8 | “Well more than half of DC backlog is non-Oracle” | Assumption | Management framing (Q1’26); customer names undisclosed — unverified |
| 9 | Price embeds ~55–85% revenue CAGR + ~20% margin through 2030 | Interpretation | Reverse-DCF sketch at ~$84B EV |
| 10 | OBBBA is a net positive for natural-gas fuel cells | Fact | 10-K; tax-counsel analyses (30% 48E, zero-GHG requirement removed) |
| 11 | $6B product backlog is partly ITC gross-up, not pure equipment revenue | Fact | FY2025 10-K “Backlog” section |
| 12 | Insider selling is benign (10b5-1/vesting), not a thesis break | Interpretation | Form 4 corpus (Apr–Jun 2026); no open-market buys |
13. Open Questions
- Revenue reconciliation: the ~$22M gap between the 10-K MD&A total ($2,024.0M) and the XBRL contracts-with-customers figure ($2,001.6M) — recast/lease-line difference to be bridged.
- Fully-diluted share count: quantify the in-the-money convertible-conversion overhang ($195 strike, $2.5B 0% notes) against the ~284M basic count.
- Customer concentration decomposition: how much of the ~43% top-customer revenue is true end-demand vs. distributor channel-fill / take-or-pay minimums? Who are the “half-dozen” hyperscalers?
- Oracle warrant terms: the market-priced warrant/strategic-partnership component of Project Jupiter — final terms and dilution undisclosed as of the Q1’26 call.
- Demand durability: is the AI on-site-power wave a multi-year secular build or a 2024–27 capex spike? (Unknowable now; track hyperscaler capex guidance and booking cadence.)
- Turbine supply timeline: when do GE Vernova/Siemens/Mitsubishi materially work down backlogs and collapse 2028 lead times?
14. What Must Be True (with falsification tests)
Bull case — what must be true:
- AI-power demand is a multi-year secular build, not a capex spike. Falsification test: a hyperscaler order pause/cancellation, or FY27 guided revenue growth decelerating below ~40%.
- Bloom defends share and pricing after turbine/SOFC supply normalizes (~2028–30) — converting a scarcity lead into a scale-plus-captivity moat. Falsification test: a credible turbine-OEM capacity announcement that collapses 2028 lead times, or a Doosan/Ceres scale ramp winning a marquee hyperscaler.
- GAAP operating margin reaches ~20% and the bottom line turns cleanly GAAP-positive. Falsification test: product gross margin printing below ~32%, or GAAP net loss persisting as revenue scales past $3B.
- The customer base genuinely broadens beyond the top three. Falsification test: the top customer staying above ~40% of revenue through FY26, or “diversified backlog” proving to be channel concentration.
Bear case — what must be true:
- The current scarcity premium is cyclical and mean-reverts. Falsification test: sustained >60% revenue growth with expanding GAAP margins for several more quarters, with turbine lead times staying long through 2029.
- The ~34x EV/revenue multiple de-rates toward a high-growth-industrial range. Falsification test: the multiple holding or expanding on a clean GAAP-profit inflection plus durable booking growth — i.e., the market re-rating BE as a proven compounder, not a momentum vehicle.
- ITC dependence and concentration bite. Falsification test: an OBBBA-era 48E framework that survives intact through the decade and demonstrable customer diversification (multiple Tier-1 names each <15%).
15. Source Appendix
See the separate Source Appendix for the full primary-source list with URLs and access dates: SEC EDGAR filings (FY2021–FY2025 10-Ks, FY2021–Q1’26 10-Qs, 8-Ks, DEF 14A 2026-04-08, Form 4 corpus); Q1’26 (2026-04-28) and Q4’25 (2026-02-05) earnings-call transcripts; AEP, Oracle, and Brookfield press releases; public market-data and news aggregators; external industry/competitor sources (GE Vernova backlog disclosures, Goldman Sachs data-center demand forecast, Doosan/Ceres production data, OBBBA tax-counsel analyses); and yfinance peer comps.
The body of this report carries no recommendation and no price target; the sole position-taking content is the clearly-labeled Claude’s Take block at the top, which is the author’s own independent view and general information only — not investment advice.
APPENDIX A — Standard Diligence Questionnaire
Bloom Energy (NYSE: BE) — Standard Diligence Questionnaire
Supplemental to the research report above. As-of 2026-06-10. Grounded in the underlying primary sources; Fact / Interpretation / Assumption labels applied where it matters.
General
What thoughtful questions have other investors asked about this company? The dominant questions, evident in the ~3x bull-bear analyst target spread (Jefferies $97 Sell to Susquehanna $293) and 11.7% short interest: (1) How much of the ~$6B product backlog is hard, near-term, ITC-ex revenue vs. framework maxima and tax-credit gross-ups? (2) Is the speed-to-power advantage durable or a temporary scarcity premium that mean-reverts when turbine supply normalizes (~2028–30)? (3) How real and diversified is data-center demand beyond Oracle — who are the “half-dozen” hyperscalers? (4) Is the margin inflection sustainable or front-loaded? (5) How should one value a GAAP-loss-making company at ~34x revenue? (6) What is the true fully-diluted share count given the $2.5B 0% convertibles? These are the right questions; the memo’s variant-perception section maps them to falsification tests.
Cyclicality & Earnings Nature
Are earnings at a cyclical high or low? Neither in a conventional sense — BE is at an early-inflection point, not a cyclical peak or trough of an established earnings base. It just turned GAAP-operating-profitable (FY24) and is scaling rapidly. But the demand driver (AI-data-center capex) is plausibly near a cyclical high (Interpretation), which is the central risk.
Driven by the external environment or internal actions? Both. Internal actions are real (cost-down, scale, Service turn, manufacturing cadence). But the magnitude of the FY25–26 acceleration is overwhelmingly an external demand shock — the AI on-site-power crunch and grid-interconnection bottleneck (Fact: 2,300 GW queue; 80 GW turbine backlog).
How stable are revenues? Low stability — ~77% is non-recurring, lumpy, project-timed product hardware, ~43% from one customer. The ~14% recurring Service+Electricity annuity is the only stable layer (but growing).
Outlook for products/services? Strong near-term (FY26 guide $3.4–3.8B, ~80% growth, raised twice). Multi-year outlook is genuinely uncertain — management itself declines 2030 guidance (“nobody has visibility past [6 months]”).
How big will this market be — growing, shrinking, domestic or international? Growing fast near-term (data-center electricity demand +~160% by 2030 per Goldman). Currently ~81% US revenue; Korea #2; Europe/India small and a few years out. The TAM is large but back-end-loaded internationally and concentrated in AI capex.
Business Quality & Competitive Moat
Is the industry getting more or less competitive? More — high returns are attracting capital (turbine OEMs adding capacity; Doosan/Ceres scaling SOFC; Bloom adding hundreds of MW/quarter). Marathon capital-cycle dynamics point to intensifying competition by ~2028–30.
How profitable is the business (ROIC, ROE)? Not meaningfully measurable today — FY25 GAAP net loss (-$87M); book value ~$3.24/sh. The forward signal is positive: ~35% product gross margin, 17.3% Q1’26 operating margin, ~3% capex intensity imply rising operating returns if scale holds. (Fact/Interpretation.)
How profitable is the industry — how many competitors, barriers to entry? Mixed. Turbine OEMs are highly profitable but supply-constrained; fuel-cell pure-plays (Plug, FuelCell Energy) are loss-making. Barriers in SOFC specifically are real (Bloom’s ~100x manufacturing-scale lead, 25 yrs of materials know-how, ~380 US patents), but the broader on-site-power market is contestable.
Can the business be easily understood? Moderately. The product and demand thesis are clear; the financing/managed-services architecture, related-party SK structure, PPA “Fund” JVs, and non-GAAP reporting add genuine complexity that warrants scrutiny.
Can it be undermined by foreign low-cost labor? Not directly — this is capital-intensive advanced manufacturing, not labor-arbitrage-exposed. The relevant foreign threat is a well-funded SOFC entrant (Doosan/Ceres), not low-cost labor.
Do brands matter? Not as consumer brands. What matters is engineering reputation, reference installs, and Tier-1 anchor wins (Oracle, AEP) — a B2B credibility moat, not a brand moat.
What is the nature of competition? Availability/speed-to-power and permitting today; levelized cost and reliability over the long run. Bloom competes on “power now, cleanly” rather than cheapest electrons.
Customers’ switching costs? Moderate and post-install: once a site islands on 100% Bloom Servers, Bloom is the sole 5–20-yr O&M provider with proprietary telemetry — re-engineering the power island is costly. No network effects.
Financial Condition & Balance Sheet
Assets not fully recognized on the balance sheet? The ~$14B service backlog and the installed-fleet annuity are economic assets not on the balance sheet (Interpretation). The IP/patent estate is carried at little book value. Conversely, the ~$6B product backlog is partly an ITC gross-up, so headline backlog overstates pure equipment revenue.
Off-balance-sheet liabilities? Watch the PPA “Fund” JV structures (equity-method, generated $40.4M equity-in-loss FY25) and ~$244M of financing/sale-leaseback obligations. Non-recourse debt has been wound down to ~$0. Capped calls partially offset convertible dilution.
How conservative is the accounting? Below-average conservatism warrants above-average scrutiny: a 2020 restatement (PPA/managed-services revenue), heavy reliance on non-GAAP metrics in guidance and compensation, related-party revenue at the center of the 43% concentration, and complex JV/PPA structures. No current material weakness reported (auditor: Deloitte). (Fact/Interpretation.)
How CapEx-hungry is the business? Strikingly low — ~$57M FY25 (~3% of revenue) to support ~5 GW of annual capacity. This “copy-exact, low capital intensity” profile is the strongest unit-economics signal and a core bull pillar.
Capital Allocation & Management
How much FCF does the business generate, and how is it used? FCF turned positive in FY24 (~+$33M) and FY25 (~+$57M) after years of ~$370–450M burn. It is reinvested into capacity and working capital; no dividend or buyback (correct for the stage).
Significant acquisitions recently? None of consequence — growth is all-organic (a low-risk posture).
Buying back shares? No.
Issuing large amounts of new shares to insiders? SBC is large and growing ($145M FY25, ~7% of revenue, +75% YoY), driven by PSUs/RSUs including the CEO’s Dec-2024 mega-grant. Cumulative dilution is ~2.2x since the 2018 IPO (~130M → ~284M shares), plus a convertible-conversion overhang.
Compensation policy of directors/management? CEO FY25 SCT comp $3.5M (no new 2025 equity grant) but “Compensation Actually Paid” ~$416M (mechanical, driven by the 291% stock surge revaluing prior grants). Incentive metrics are operationally sound (non-GAAP operating income, revenue, product-revenue-growth, adjusted product gross margin) — i.e., paid on the right levers — but the magnitude (300% PSU / 200% cash-bonus payouts) is extreme and the metrics are non-GAAP (circular re: SBC).
Motivations of management? Founder-CEO (KR Sridhar, 25 years) with a mission-driven “decarbonize/light up the planet” framing and high equity sensitivity. Aligned to the upside; the risk is over-promotion and the non-GAAP framing. Insider transactions are net selling into the spike (all 10b5-1/vesting; zero open-market buys) — mildly cautious, weak signal.
Valuation & Market Data
Is the stock an ADR, MLP, or K-1 issuer? No — BE is a U.S. domestic C-corp common stock (NYSE), standard 1099 treatment. (Legacy dual-class Class B is now dead-letter and being cleaned up.)
Dividend policy? None; no dividend, no buyback.
How profitable is the business? GAAP-operating-profitable (+$73M FY25) but GAAP-net-unprofitable (-$87M FY25) after interest, a debt-extinguishment loss, and JV equity-losses. Non-GAAP profitable.
Is net income diverging from cash from operations? Yes, favorably — FY25 GAAP net loss (-$87M) vs. positive operating cash flow (+$114M), the gap reflecting non-cash SBC ($145M), working-capital timing, and below-operating-line financing/JV items. This is a quality positive (cash conversion better than GAAP earnings), but the non-cash SBC driving the gap is a real economic dilution cost.
Risks & Downside
What factors would cause the stock to decline? (1) Valuation de-rating toward peers (the dominant risk — even with growth, a multiple collapse loses most of the value); (2) AI-capex air-pocket; (3) turbine/genset supply catching up and compressing the scarcity premium; (4) a guided revenue deceleration or product-margin roll-over; (5) an adverse ITC reinterpretation; (6) a customer-concentration shock (SK/top-customer); (7) dilution from convertible conversion. Beta 3.83 amplifies all of these.
Risk of a catastrophic loss? A valuation-driven catastrophic loss to capital is plausible (the bear case is ~-90% from $260) even without a fundamental break, purely via multiple compression on a ~34x-revenue stock.
Chance of a total loss? Low. ~$2.45B cash, FCF-positive operations, net-neutral cheap convertible debt, real technology and a real order book — insolvency is not the risk; price is.
Recent News & Events
Has the business environment changed recently? Dramatically and favorably on demand (the AI on-site-power pivot, FY26 guidance raised twice), and favorably on policy (OBBBA restored a 30% 48E ITC for natural-gas fuel cells). The change set is net thesis-strengthening (memo the relevant section).
Significant acquisitions? None; the landmark events are commercial/financing relationships (AEP $2.65B definitive Jan-2026; Oracle Project Jupiter up to 2.45 GW Apr-2026; Brookfield up to $5B Oct-2025) and the $2.5B 0% convertible raise (Oct-2025).
Change in accounting policies? None material recently; the relevant history is the 2020 restatement and ongoing non-GAAP reliance.
Recent changes — new markets, facilities, management? New CFO (Simon Edwards, ~Apr-2026); continuous manufacturing expansion toward 5 GW (Fremont + Newark); geographic shift of US backlog from CA/Northeast to lower-power-cost states; charter amendments (officer exculpation + Class B cleanup, May-2026 — not a declassification).
Recent-events timeline (last ~18 months):
| Date | Event |
|---|---|
| 2024-11-14 | AEP up-to-1 GW fuel-cell procurement option — largest commercial fuel-cell procurement to date |
| 2025-07-10 | SK ecoplant ceases to be a related party (sells down to ~2.5%) |
| 2025-10-13 | Brookfield up-to-$5B AI-infrastructure financing partnership |
| 2025-10-30 | $2.2B (upsized) 0% convertible notes due 2030 priced (conversion ~$195) |
| 2026-01-04 | AEP definitive $2.65B unconditional purchase agreement + 20-yr offtake (Cheyenne, WY) |
| 2026-02-05 | Q4/FY25 results: revenue $2.0B (+37%), product backlog ~$6B; FY26 guide $3.1–3.3B |
| 2026-04-27 | Oracle “Project Jupiter” — up to 2.45 GW, 100% Bloom (turbines/diesel designed out) |
| 2026-04-28 | Q1’26 results: revenue $751M (+130% YoY); FY26 guide RAISED to $3.4–3.8B; new CFO Simon Edwards |
| 2026-05-21/26 | Annual meeting: charter amendments (officer exculpation + Class B cleanup; NOT declassification) |
| 2026-06-09 | Federal court strikes down IRS rule limiting wind/solar credits — clean-energy sector tailwind |
public market-data aggregator sentiment skew (signal, not evidence — treat as hypothesis): net positive but dominated by price-action and listicle noise; the only “important”-scored items are the June-9 court ruling (positive, sector-level) and a governance/contracts recap (positive). No material adverse fundamental headline (no guidance cut, contract loss, litigation, or accounting flag) in the recent feed — consistent with a stock contending with valuation gravity after running hard on confirmed good news.
APPENDIX B — Source Appendix
Bloom Energy (NYSE: BE) — Source Appendix
Primary sources prioritized over secondary. Access date 2026-06-10 unless noted.
A. SEC Filings (EDGAR — CIK 0001664703)
| Form | Period / Date | Use |
|---|---|---|
| 10-K (FY25) | filed 2026-02-09 | Business (Item 1), segment revenue, concentration note, margins, convertible notes, SK ecoplant, JV losses, backlog, risk factors, ITC/OBBBA disclosure |
| 10-K (FY24) | filed 2025-02-15 | Prior-year baseline; segment costs; gross-margin progression |
| 10-K (FY23) | filed 2024-02-15 | Service-segment loss history; restatement context |
| 10-K (FY22) | filed 2023-02-21 | FY22 revenue/margin baseline |
| 10-Q (Q1’26) | filed 2026-04-29 | Q1’26 revenue $751M (+130%), op margin 17.3%, operating cash flow |
| 10-Q series | 2021–2025 | Quarterly revenue/margin/cash trajectory |
| 8-K | 2026-04-28 (Q1’26 earnings) | Guidance raise; new CFO |
| 8-K | 2026-02-05 (Q4’25 earnings) | FY25 results; initial FY26 guide |
| 8-K | 2026-01-04 (AEP) | AEP $2.65B definitive unconditional purchase agreement |
| 8-K | 2025-10-30 (converts) | $2.2B (upsized) 0% convertible notes due 2030 |
| 8-K | 2026-05-21/27 (charter) | Charter amendments: officer exculpation + Class B cleanup |
| DEF 14A | filed 2026-04-08 | Executive comp metrics, CAP table, incentive design, governance |
| Form 4 corpus | Apr–Jun 2026 | Insider transactions (Chambers, Soderberg, Bush, Joshi, Chitoori, Sridhar) — 10b5-1 sales, option exercises, RSU grants; no open-market buys |
| EDGAR XBRL | companyconcept API | Authoritative reconciliation: Revenue, GrossProfit, OperatingIncomeLoss, NetIncomeLoss, Cash |
B. Earnings-Call / Event Transcripts
| Date | Event | Use |
|---|---|---|
| 2026-04-28 | Q1-2026 earnings call | +130% YoY; FY26 guide raise; Oracle/AEP framing; CFO intro |
| 2026-02-05 | Q4-2025 earnings call | FY25 results; backlog ~$6B product / ~$14B service; FY26 guide |
| 2025-10-28 | Q3-2025 earnings call | Margin cadence; related-party (~55% Q3) detail |
| 2025-07-31 | Q2-2025 earnings call | Demand inflection commentary |
| 2025-04-30 | Q1-2025 earnings call | Pre-inflection baseline |
| (catalog) | conference presentations / special calls 2018–2026 | Strategy/forward framing |
Management commentary is treated as hypothesis (the relevant section rule 8) and validated against filings and external data.
C. Company / Counterparty Press Releases
- Oracle / BorderPlex / Bloom — “Project Jupiter” up to 2.45 GW, New Mexico (2026-04-27).
- AEP — up-to-1 GW fuel-cell procurement option (2024-11-14); $2.65B definitive purchase agreement (2026-01-04).
- Brookfield / Bloom — up-to-$5B AI-infrastructure financing partnership; first 55 MW US tranche (2025-10-13).
- Bloom Energy — $2.2B (upsized) 0% convertible senior notes due 2030 (2025-10-30).
D. Quantitative Feeds & Tools
- SEC EDGAR XBRL (companyconcept API) — authoritative revenue/margin/income/cash reconciliation.
- Public market-data aggregators — valuation highlights, short interest, ownership, and own-history valuation percentiles (composite 95th, P/S 99th, P/B 91st). Statement detail was taken directly from the 10-K/10-Q and SEC EDGAR XBRL rather than third-party aggregated statement arrays.
- public market-data aggregator — recent-events triage (June-9 court ruling; governance/contracts recap). Scores treated as signal, not evidence.
- yfinance — peer comps (GEV, ETN, VRT, PWR, GNRC, NVT, PLUG); reconciled to filings.
E. External Industry / Competitor Sources
- GE Vernova turbine-backlog disclosures (~80 GW, sold out toward 2030) — Utility Dive / Power Engineering, 2025–26.
- Goldman Sachs — global data-center electricity demand forecast (~+160% by 2030), 2025.
- U.S. interconnection-queue data (~2,300 GW at end-2024) — cited in FY2025 10-K.
- Doosan Fuel Cell / Ceres Power — 50 MW SOFC factory mass production (Jul-2025); first 9 MW commercial order (Dec-2025).
- Plug Power, FuelCell Energy — FY25 results (net losses, negative gross margins) — company filings / press.
- OBBBA (One Big Beautiful Bill Act, 2025) fuel-cell ITC analysis — tax-counsel commentaries (Pierce Atwood, JMCO); corroborated by 10-K language.
- Federal court ruling vacating IRS rule on wind/solar credits — Benzinga, 2026-06-09 .
- Sell-side coverage / price-target dispersion — 247WallSt / TIKR aggregation, Apr–May 2026 (Susquehanna $293; JPMorgan $267; Jefferies $97 Sell; Street mean ~$223).